RGO
Regeneron Pharmaceuticals, Inc. · SWB:RGO
862.20 EUR34.30 +4.14%
Regeneron Pharmaceuticals, Inc. (SWB:RGO) last traded at 862.20 EUR, up 4.14% on the day. Over the past year the stock is up 54.63%. Its 52-week range is 509.50 to 867.20. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open821.20
Day range821.20 – 867.20
52-week range509.50 – 867.20
Volume5
Average volume (10 days)15
Market cap (USD)95.51 B
P/E21.56
EPS (TTM) (USD)45.30
Dividend yield0.40%
Beta (1 year)0.0814
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
+20.45%1 week
+32.36%1 month
+31.09%3 months
+44.45%6 months
+31.55%Year to date
+54.63%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Morgan Stanley maintains Regeneron Pharmaceuticals at Equal-Weight, raises price target to $855 from $779TradingView · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
- Truist Securities maintains Regeneron Pharmaceuticals at Buy, raises price target to $982 from $780TradingView · 02 Nov 2026
- RBC Capital maintains Regeneron Pharmaceuticals at Sector Perform, raises price target to $913 from $810TradingView · 02 Nov 2026
- Regeneron Pharma Is Maintained at Buy by GuggenheimDow Jones Newswires · 02 Nov 2026
- Guggenheim maintains Regeneron Pharmaceuticals at Buy, raises price target to $1100 from $1030TradingView · 02 Nov 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.